Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development.
about
Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniaeA Compendium for Mycoplasma pneumoniaeAntibody Response to Mycoplasma pneumoniae: Protection of Host and Influence on Outbreaks?Network of Surface-Displayed Glycolytic Enzymes in Mycoplasma pneumoniae and Their Interactions with Human PlasminogenSubunits of the Pyruvate Dehydrogenase Cluster of Mycoplasma pneumoniae Are Surface-Displayed Proteins that Bind and Activate Human PlasminogenDelineation of immunodominant and cytadherence segment(s) of Mycoplasma pneumoniae P1 geneDomain analysis of protein P30 in Mycoplasma pneumoniae cytadherence and gliding motilityCyto-adherence of Mycoplasma mycoides subsp. mycoides to bovine lung epithelial cells.Analysis of the Mycoplasma genitalium MgpB Adhesin to Predict Membrane Topology, Investigate Antibody Accessibility, Characterize Amino Acid Diversity, and Identify Functional and Immunogenic Epitopes.Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in MiceEffects of Traditional Chinese Medicine Qinbai Qingfei Concentrated Pellet on Cellular Infectivity of Mycoplasma pneumoniae.The surface-displayed chaperones GroEL and DnaK of Mycoplasma pneumoniae interact with human plasminogen and components of the extracellular matrix.Evaluation of P1 adhesin epitopes for the serodiagnosis of Mycoplasma pneumoniae infections.Protective efficacy of a Mycoplasma pneumoniae P1C DNA vaccine fused with the B subunit of Escherichia coli heat-labile enterotoxin.Subtypes and variants of Mycoplasma pneumoniae: local and temporal changes in Germany 2003-2006 and absence of a correlation between the genotype in the respiratory tract and the occurrence of genotype-specific antibodies in the sera of infected patMycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.
P2860
Q26744683-F151F0E4-CB8A-4036-88E1-20FC31AF82A5Q26752589-543C0B08-67E8-4C5B-9DA0-C9CAB1B4EA42Q26767481-99C4BB44-E397-409E-95A5-85BCECA1AF92Q28118121-391F64E1-AFD5-4B7E-B93D-246DA1710B50Q28901913-CEBC41C1-317B-4926-83AF-EB6BF00BCA2BQ33611874-45ED6007-DD90-4107-910F-3452CAD917B6Q34740858-9DF653A6-4F10-4949-80F3-DE522545E359Q35108634-482BE8DB-2112-4A02-9635-4C174FC5332EQ35779686-FBF206D7-8126-4B81-BD01-2CD2BFB9C40FQ36106791-0784F9BD-89B1-4812-B6B4-5B6D48500512Q36978977-282EFF45-F815-4F08-A4F8-6690AF22047AQ40330838-ECD5808F-7109-4CEB-93CC-04D21BD3FE4DQ44986011-BCC58FF2-2E70-45B3-8F65-35E7F8C0EC2BQ54335551-7B8727E5-9F84-4A37-8B0B-2450EF1724CEQ54435430-5CB646EC-6C98-4A84-A094-F8D32E7D8C96Q55491171-15A2C10C-804F-4DB5-A9C9-F5A8F00E5F7F
P2860
Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Strategy to create chimeric pr ...... oniae for vaccine development.
@en
Strategy to create chimeric pr ...... oniae for vaccine development.
@nl
type
label
Strategy to create chimeric pr ...... oniae for vaccine development.
@en
Strategy to create chimeric pr ...... oniae for vaccine development.
@nl
prefLabel
Strategy to create chimeric pr ...... oniae for vaccine development.
@en
Strategy to create chimeric pr ...... oniae for vaccine development.
@nl
P2093
P2860
P356
P1476
Strategy to create chimeric pr ...... oniae for vaccine development.
@en
P2093
Enno Jacobs
Nicol Schurwanz
Roger Dumke
P2860
P304
P356
10.1128/IAI.00268-09
P407
P577
2009-08-10T00:00:00Z